These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

886 related items for PubMed ID: 7989603

  • 1. Human ApoA-II inhibits the hydrolysis of HDL triglyceride and the decrease of HDL size induced by hypertriglyceridemia and cholesteryl ester transfer protein in transgenic mice.
    Zhong S, Goldberg IJ, Bruce C, Rubin E, Breslow JL, Tall A.
    J Clin Invest; 1994 Dec; 94(6):2457-67. PubMed ID: 7989603
    [Abstract] [Full Text] [Related]

  • 2. Hypertriglyceridemia and cholesteryl ester transfer protein interact to dramatically alter high density lipoprotein levels, particle sizes, and metabolism. Studies in transgenic mice.
    Hayek T, Azrolan N, Verdery RB, Walsh A, Chajek-Shaul T, Agellon LB, Tall AR, Breslow JL.
    J Clin Invest; 1993 Sep; 92(3):1143-52. PubMed ID: 8376576
    [Abstract] [Full Text] [Related]

  • 3. Human apoA-I expression in CETP transgenic rats leads to lower levels of apoC-I in HDL and to magnification of CETP-mediated lipoprotein changes.
    Masson D, Pais de Barros JP, Zak Z, Gautier T, Le Guern N, Assem M, Chisholm JW, Paterniti JR, Lagrost L.
    J Lipid Res; 2006 Feb; 47(2):356-65. PubMed ID: 16282639
    [Abstract] [Full Text] [Related]

  • 4. Apolipoprotein A-I metabolism in cholesteryl ester transfer protein transgenic mice. Insights into the mechanisms responsible for low plasma high density lipoprotein levels.
    Melchior GW, Castle CK, Murray RW, Blake WL, Dinh DM, Marotti KR.
    J Biol Chem; 1994 Mar 18; 269(11):8044-51. PubMed ID: 8132527
    [Abstract] [Full Text] [Related]

  • 5. ApoA-II expression in CETP transgenic mice increases VLDL production and impairs VLDL clearance.
    Escolà-Gil JC, Julve J, Marzal-Casacuberta A, Ordóñez-Llanos J, González-Sastre F, Blanco-Vaca F.
    J Lipid Res; 2001 Feb 18; 42(2):241-8. PubMed ID: 11181754
    [Abstract] [Full Text] [Related]

  • 6. Mechanisms of enhancement of cholesteryl ester transfer protein activity by lipolysis.
    Sammett D, Tall AR.
    J Biol Chem; 1985 Jun 10; 260(11):6687-97. PubMed ID: 3838987
    [Abstract] [Full Text] [Related]

  • 7. Comparative effects of purified apolipoproteins A-I, A-II, and A-IV on cholesteryl ester transfer protein activity.
    Guyard-Dangremont V, Lagrost L, Gambert P.
    J Lipid Res; 1994 Jun 10; 35(6):982-92. PubMed ID: 8077854
    [Abstract] [Full Text] [Related]

  • 8. Decreased early atherosclerotic lesions in hypertriglyceridemic mice expressing cholesteryl ester transfer protein transgene.
    Hayek T, Masucci-Magoulas L, Jiang X, Walsh A, Rubin E, Breslow JL, Tall AR.
    J Clin Invest; 1995 Oct 10; 96(4):2071-4. PubMed ID: 7560101
    [Abstract] [Full Text] [Related]

  • 9. Lipoprotein lipase enhances the cholesteryl ester transfer protein-mediated transfer of cholesteryl esters from high density lipoproteins to very low density lipoproteins.
    Tall AR, Sammett D, Vita GM, Deckelbaum R, Olivecrona T.
    J Biol Chem; 1984 Aug 10; 259(15):9587-94. PubMed ID: 6746661
    [Abstract] [Full Text] [Related]

  • 10. Differential interaction of the human cholesteryl ester transfer protein with plasma high density lipoproteins (HDLs) from humans, control mice, and transgenic mice to human HDL apolipoproteins. Lack of lipid transfer inhibitory activity in transgenic mice expressing human apoA-I.
    Masson D, Duverger N, Emmanuel F, Lagrost L.
    J Biol Chem; 1997 Sep 26; 272(39):24287-93. PubMed ID: 9305883
    [Abstract] [Full Text] [Related]

  • 11. Decreased cholesteryl ester transfer protein (CETP) mRNA and protein and increased high density lipoprotein following lipopolysaccharide administration in human CETP transgenic mice.
    Masucci-Magoulas L, Moulin P, Jiang XC, Richardson H, Walsh A, Breslow JL, Tall A.
    J Clin Invest; 1995 Apr 26; 95(4):1587-94. PubMed ID: 7706465
    [Abstract] [Full Text] [Related]

  • 12. Influence of lipoprotein lipase and hepatic lipase on the transformation of VLDL and HDL during lipolysis of VLDL.
    Murdoch SJ, Breckenridge WC.
    Atherosclerosis; 1995 Dec 26; 118(2):193-212. PubMed ID: 8770314
    [Abstract] [Full Text] [Related]

  • 13. Human apolipoprotein A-II determines plasma triglycerides by regulating lipoprotein lipase activity and high-density lipoprotein proteome.
    Julve J, Escolà-Gil JC, Rotllan N, Fiévet C, Vallez E, de la Torre C, Ribas V, Sloan JH, Blanco-Vaca F.
    Arterioscler Thromb Vasc Biol; 2010 Feb 26; 30(2):232-8. PubMed ID: 19910634
    [Abstract] [Full Text] [Related]

  • 14. An interaction between the human cholesteryl ester transfer protein (CETP) and apolipoprotein A-I genes in transgenic mice results in a profound CETP-mediated depression of high density lipoprotein cholesterol levels.
    Hayek T, Chajek-Shaul T, Walsh A, Agellon LB, Moulin P, Tall AR, Breslow JL.
    J Clin Invest; 1992 Aug 26; 90(2):505-10. PubMed ID: 1644921
    [Abstract] [Full Text] [Related]

  • 15. Remodeling of HDL by CETP in vivo and by CETP and hepatic lipase in vitro results in enhanced uptake of HDL CE by cells expressing scavenger receptor B-I.
    Collet X, Tall AR, Serajuddin H, Guendouzi K, Royer L, Oliveira H, Barbaras R, Jiang XC, Francone OL.
    J Lipid Res; 1999 Jul 26; 40(7):1185-93. PubMed ID: 10393203
    [Abstract] [Full Text] [Related]

  • 16. Molecular determinants of plasma cholesteryl ester transfer protein binding to high density lipoproteins.
    Bruce C, Davidson WS, Kussie P, Lund-Katz S, Phillips MC, Ghosh R, Tall AR.
    J Biol Chem; 1995 May 12; 270(19):11532-42. PubMed ID: 7744792
    [Abstract] [Full Text] [Related]

  • 17. Increased prebeta-high density lipoprotein, apolipoprotein AI, and phospholipid in mice expressing the human phospholipid transfer protein and human apolipoprotein AI transgenes.
    Jiang X, Francone OL, Bruce C, Milne R, Mar J, Walsh A, Breslow JL, Tall AR.
    J Clin Invest; 1996 Nov 15; 98(10):2373-80. PubMed ID: 8941656
    [Abstract] [Full Text] [Related]

  • 18. Apolipoprotein CI deficiency markedly augments plasma lipoprotein changes mediated by human cholesteryl ester transfer protein (CETP) in CETP transgenic/ApoCI-knocked out mice.
    Gautier T, Masson D, Jong MC, Duverneuil L, Le Guern N, Deckert V, Pais de Barros JP, Dumont L, Bataille A, Zak Z, Jiang XC, Tall AR, Havekes LM, Lagrost L.
    J Biol Chem; 2002 Aug 30; 277(35):31354-63. PubMed ID: 12070157
    [Abstract] [Full Text] [Related]

  • 19. Thyroid hormone increases plasma cholesteryl ester transfer protein activity and plasma high-density lipoprotein removal rate in transgenic mice.
    Berti JA, Amaral ME, Boschero AC, Nunes VS, Harada LM, Castilho LN, Oliveira HC.
    Metabolism; 2001 May 30; 50(5):530-6. PubMed ID: 11319713
    [Abstract] [Full Text] [Related]

  • 20. Cholesteryl ester transfer activity in liver disease and cholestasis, and its relation with fatty acid composition of lipoprotein lipids.
    Iglesias A, Arranz M, Alvarez JJ, Perales J, Villar J, Herrera E, Lasunción MA.
    Clin Chim Acta; 1996 Apr 30; 248(2):157-74. PubMed ID: 8740580
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 45.